IgA anti-CD74 autoantibodies are associated with treatment escalation in peripheral psoriatic arthritis

BackgroundPsoriatic arthritis (PsA) often requires escalation from conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) to biologic therapy (bDMARDs), yet biomarkers guiding treatment decisions remain limited. Anti-CD74 autoantibodies have shown diagnostic potential in axial spond...

Description complète

Détails bibliographiques

Auteurs principaux:	Alaa Elsaghir, Luise Kuske, Katja Kniesch, Miriam Rabenow, Till Strowig, Torsten Witte
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2026-05-01
Collection:	Frontiers in Immunology
Sujets:	psoriatic arthritis peripheral psoriatic arthritis IgA anti-CD74 biomarker treatment escalation bDMARDs
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1821206/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!